4//SEC Filing
Arcudi III Louis J 4
Accession 0001209191-11-060028
CIK 0000861838other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 4:24 PM ET
Size
8.3 KB
Accession
0001209191-11-060028
Insider Transaction Report
Form 4
Arcudi III Louis J
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2011-12-05+50,000→ 50,000 totalExercise: $1.16Exp: 2021-11-28→ Common Stock (50,000 underlying) - Award
Stock Option (Right to Buy)
2011-12-05+50,000→ 50,000 totalExercise: $1.16From: 2012-11-28Exp: 2021-11-28→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The various numbers listed in Columns 5, 7 and 9 relate to a single option grant which entitled the reporting person to purchase up to an aggregate of 200,000 shares of the issuer's common stock. The option to purchase the remaining 100,000 shares of the issuer's common stock is subject to satisfaction of performance-based vesting criteria.
- [F2]The option vests over four years in 16 equal quarterly installments beginning on February 28, 2012.
Documents
Issuer
IDERA PHARMACEUTICALS, INC.
CIK 0000861838
Entity typeother
Related Parties
1- filerCIK 0001419350
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 4:24 PM ET
- Size
- 8.3 KB